External Lyogel Formulation of Prostaglandin E1 Ethyl Ester |
Yang, Sung-Woon
(Formulation Lab. Guju Pharmaceutical Co. Ltd.)
Lee, Jin-Kyo (Formulation Lab. Guju Pharmaceutical Co. Ltd.) Lee, Ji-Eun (Formulation Lab. Guju Pharmaceutical Co. Ltd.) Kim, Hee-Kyu (College of Pharmacy, Chung-Ang University) Park, Hye-Sook (College of Pharmacy, Chung-Ang University) Kim, Jong-Seok (College of Pharmacy, Chung-Ang University) Choi, Han-Gon (College of Pharmacy, Yeungnam University) Yong, Chul-Soon (College of Pharmacy, Yeungnam University) Choi, Young-Wook (College of Pharmacy, Chung-Ang University) |
1 | T.F. Lue, Erectile dysfunction, N. Engl. J. Med., 342, 1802-1813 (2000) DOI ScienceOn |
2 | T. Tarcan, K.M. Azadzoi, M.B. Siroky, I. Goldstein and R.J. Krane, Age-related erectile and voiding dysfunction: The role of arterial insufficiency, Br. J. Urol., Suppl., 82, 26-33 (1998) DOI |
3 | G. Williams, C.C. Abbou, E.T. Amar, P. Desvaux, T.A. Flam, G.A.B. Lycklama Nijeholt, S.F. Lynch, R.J. Morgan, S.C. M ller, H. Porst, J.P. Pryor, P. Ryan, U.K.F. Witzsch, M.M. Hall, V.A. Place, A.P. Spivack and N. Gesundheit, Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction, Br. J. Urol., 81, 889-894 (1998) DOI |
4 | H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane and J.B. Mekinlay, Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study, J. Urol., 151, 54-61 (1991) |
5 | J.E. Morlev and F.E. Kaiser, Impotence: the internist's approach to diagnosis and treatment, Adv. Intern. Med., 38, 151-168 (1993) |
6 | G. Cavallini, Minoxidil versus nitroglycerine : a prospective double-blind controlled trial in transcutaneous erection facilitation for organic impotence, J. Urol., 146, 50-52 (1991) DOI |
7 | E.D. Kim, E.I. Rashidy and K.T. Macvary, Papaverine topical gel for treatment of erectile dysfunction, J. Urol., 153, 361-365 (1995) DOI ScienceOn |
8 | J. Feenstra, R.J.H.M. van Drie-Pierik, C.F. Lacle and B.H.C. Stricker, Acute myocardial infarction associated with sildenafil, Lancet, 352, 957-958 (1998) DOI ScienceOn |
9 | NIH Concensus Development Panel on Impotence, NIH Consensus Conference, impotence. JAMA 270, 83-90 (1993) |
10 | U. Gresser and C.H. Gleiter, Erectile dysfunction: Comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil- Review of the literature, Eur. J. Med. Res., 7, 435-446, (2002) |
11 | J.N. Weiss, G.H. Badlani, R. Ravelli and N. Brettschneider, Reason for high drop out rate with self injection therapy for impotence, Int. J. Impotence Res., 6, 171-174 (1994) |
12 | P. Ekman, L. Sj gren, G. Englund and G.E. Persson, Optimizing the therapeutic approach of transurethral alprostadil, BJU Int., 86, 68-74 (2000) DOI ScienceOn |
13 | P. Werthman and J. Rajfer, Muse therapy: Preliminary clincal observations, Urology, 50, 809-811 (1997) DOI ScienceOn |
14 | A.W. Zorgniotti and R.S. Lefleur, Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence, J. Urol., 133, 39-41 (1985) DOI |
15 | M.T. Sheu, L.H. Lin, B.W. Spur, P.Y.K. Wong and H.S. Chiang, Investigation of the percutaneous penetration of prostaglandin and its ethyl ester, J. Controlled Release, 55, 153-160 (1998) DOI ScienceOn |
16 | P.F. Fulgham, J.S. Cochran, J.L. Denman, B.A. Feagins, M.B. Gross, K.T. Kadesky, M.C. Kadesky, A.R. Clark and C.G. Roehrborn, Disappointing initial results with transcurethral alprostadil for erectile dysfunction in a urology practice setting, J. Urol., 160, 2041-2046 (1998) DOI ScienceOn |
17 | R. Virag, Intracavernous injection of papaverine for erectile failure, Letter to the editor, Lancet, 2, 938 (1982) |
18 | F. Montorsi, G. Guazzoni, P. Rigatti and G. Pozza, Pharmacological management of erectile dysfunction, Drugs, 50, 465-479 (1995) DOI ScienceOn |
19 | M. Lakin, The evaluation and nonsurgical managment of impotence, Semin. Nephrol., 14, 544-550 (1994) |
20 | E.J. Keogh, Pharmacotherapy for impotence, Current Opinion in Urology, 4, 363-339 (1994) |
21 | R.J. Krane, Editorial : Impotence, J. Urol., 153, 1841-1842 (1995) |
22 | D.C. Anderson and C.F. Seifert, Topical nitrate treatment of impotence, Ann. Pharmacother., 27, 1203-1205 (1993) |
23 | Y. Obata, K. Takayama, Y. Machida and T. Nagai, Combined effect of cyclic monoterpenes and ethanol on percutaneous absorption of diclofenac sodium, Drug Design Del., 8, 137-144 (1991) |
24 | D. Kobayash, T. Matsuzawa, K. Sugibayashi, Y. Morimoto, M. Kobayashi and M. Kimura, Feasibility of use of several cardiovascular agents in transdermal therapeutic systems with l-menthol-ethanol system on hairless rat and human skin, BioI. Pharm. Bull., 16, 254-258 (1993) DOI ScienceOn |
25 | J. Chen, M.F. Godschalk, P.G. Katz, and T. Mulligan, Incidence of penile pain after injection of a new formulation of prostaglandin , J. Urol., 154, 77-79 (1995) DOI ScienceOn |
26 | M.A. Yamane, A.C. Williams and B.W. Barry, Terpene penetration enhancer in propylene glycol/water cosolvent systems: effectiveness and mechanism of action, J. Pharm. Pharmacal., 47, 978-989 (1995) DOI |
27 | L.S. Palmer, M. Valcic, A. Melman, A. Giraldi, G. Wagner and G.J. Christ, Characterization of cyclic AMP accumulation in cultured human corpus cavernosum smooth muscle cells, J. Urol., 152, 1308-1314 (1994) DOI |
28 | N. Ishii, H. Watanabe, C. Irisawa, Y. Kikuchi, S. Kawanura, K. Suzuki, R. Chiba and M. Tokiwa, Studies on male sexual impotence report: Therapeutic trial with prostaglandin for organic impotence, Jap. J. Urol., 77, 954-962 (1986) DOI |
29 | P. Schramek, R. Dorninger, M. Waldhauser, P. Konency and P. Porpzczy, Prostaglandin in erectile dysfunction: Efficiency and incidence of priapism, Brit. J. Urol., 65, 68-71 (1990) DOI ScienceOn |
30 | W.W. Kerfoot and C.C. Carson, Pharmacologically induced erections among geriatric men, J. Urol., 146, 1022-1024 (1991) DOI |
31 | M. Waldhauser and P. Schramek, Efficiency and side effect of prostaglandin in the treatment of erectile dysfunction, J. Urol., 140, 525-527 (1988) DOI |
32 | M.K. Irwin and E.J. Kata, High attrition rate with intracavernous injection of prostaglandin for impotency, Urology, 43, 84-87 (1994) DOI ScienceOn |
33 | L.H. Lin, H.O. Ho, K.T. Chen, H.S. Chiang and M.T. Sheu, Stability of prostaglandin ethylester, Chin. Pharm. J., 50, 97-105 (1998) |
34 | H.O. Ho, M.C. Hwang, S.L. Tseng, L.H. Lin, K.T. Chen, H.S. Chiang, B.W. Spur, P.Y.K. Wong and M.T. Sheu, The percutaeneous penetration of prostaglandin and its alkyl esters, J. Controlled Release, 58, 349-355 (1999) DOI ScienceOn |
35 | H. Adach, T. Irie, F. Hirayama and K. Uekama, Stabilization of prostaglandin in fatty alcohol propylene glycol ointment by acidic cyclodextrin derivative O-carboxymethyl-ethyl--cyclodextrin, Chem. Pharm. Bull., 40, 1586-1591 (1992) DOI |
36 | R.G. Stehle and T.O. Oesterling, Stability of prostaglandin and dinoprostone(prostaglandin ) under strongly acidicand basic conditions, J. Pharm. Sci., 62, 1590-1595 (1977) |
37 | K.K. Levision, K. Takayama, K. lsowa, K. Okabe and T. Nagai, Formulation optimization of indomethacin gels contaning a combination of three kinds of cyclic monoterpenes as percutaneous penetraton enhancer, J. Pharm. Sci., 83, 1367-1372 (1994) DOI ScienceOn |
38 | H. Okabe, K Takayama and T. Nagai, Percutaneous absorption of ketoprofen from acrylic gel patches containing d-limonene and ethanol as absroption enhancer, Chem. Pharm. Bull., 40, 1906-1910 (1992) DOI ScienceOn |
39 | A.C. Williams and B.W. Barry, Terpenes and the lipid-protein-partitioning theory of skin penetraton enhancement, Pharm. Res., 8, 17-24 (1991) DOI ScienceOn |
40 | J.Y. Fang, C.T. Kuo, Y.B. Huang, P.C. Wu and Y.H. Tsai, Transdermal delivery of sodium nonivamide acetate from volatile vehicles: effects of polymers, Int. J. Pharm., 176, 157-167 (1999) |